Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer

Japanese Journal of Clinical Oncology

Volumn 45, Issue 11, 2015, Pages 1055-1063

  Li, Hui Jin ^a   Li, Xu ^a   Pang, Huan ^a   Pan, Jing Jing ^a   Xie, Xiao Juan ^a   Chen, Wei ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Bladder cancer; GLS2; lncRNA; MiR 16; UCA1

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; GLUTAMINASE; GLUTAMINASE 2; GLUTAMINE; LONG UNTRANSLATED RNA; MESSENGER RNA; MICRORNA 16; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; UROTHELIAL CARCINOMA ASSOCIATED 1 PROTEIN; GLS2 PROTEIN, HUMAN; MICRORNA; MIRN16 MICRORNA, HUMAN; UCA1 RNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; AMINO ACID METABOLISM; ARTICLE; BINDING SITE; BLADDER CANCER; BLADDER CANCER CELL LINE; BLADDER TISSUE; CLINICAL ARTICLE; FEMALE; FLUORESCENCE MICROSCOPE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOLECULAR MECHANICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BLADDER TUMOR; GENETICS; METABOLISM; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; GLUTAMINASE; GLUTAMINE; HUMANS; MICRORNAS; REACTIVE OXYGEN SPECIES; RNA, LONG NONCODING; URINARY BLADDER NEOPLASMS;

EID: 84949757580     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyv132     Document Type: Article

References (29)

1. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004;4:891-9.
2. Bauer G. Targeting extracellular ROS signaling of tumor cells. Anticancer Res 2014;34:1467-82.
3. Bellot GL, Liu D, Pervaiz S. ROS, autophagy, mitochondria and cancer: Ras, the hidden master? Mitochondrion 2013;13:155-62.
4. Ziech D, Franco R, Pappa A, Panayiotidis MI. Reactive oxygen species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis. Mutation Res 2011;711:167-73.
5. Shanware NP, Mullen AR, DeBerardinis RJ, Abraham RT. Glutamine: pleiotropic roles in tumor growth and stress resistance. J Mol Med (Berlin, Germany) 2011;89:229-36.
6. Rajagopalan KN, DeBerardinis RJ. Role of glutamine in cancer: therapeutic and imaging implications. J Nucl Med 2011;52:1005-8.
7. Hensley CT, Wasti AT, DeBerardinis RJ. Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest 2013;123:3678-84.
8. Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci 2010;35:427-33.
9. Zhang J, Wang C, Chen M, et al. Epigenetic silencing of glutaminase 2 in human liver and colon cancers. BMC Cancer 2013;13:601.
10. D'Autreaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Bio 2007;8:813-24.
11. Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 2012;9:703-19.
12. Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene 2012;31: 4577-87.
13. Cesana M, Cacchiarelli D, Legnini I, et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011;147:358-69.
14. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 2011;146:353-8.
15. Jacobs BL, Lee CT, Montie JE. Bladder cancer in 2010: how far have we come? CA Cancer J Clin 2010;60:244-72.
16. Yang C, Li X, Wang Y, Zhao L, Chen W. Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene 2012;496:8-16.
17. Wang F, Li X, Xie X, Zhao L, Chen W. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett 2008;582:1919-27.
18. Jiang M, Huang O, Xie Z, et al. A novel long non-coding RNA-ARA: adriamycin resistance-associated. Biochem Pharmacol 2014;87:254-83.
19. Han Y, Yang YN, Yuan HH, et al. UCA1, a long non-coding RNA upregulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution. Pathology 2014;46:396-401.
20. WuW, Zhang S, Li X, Xue M, Cao S, ChenW. Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long non-coding RNA, in bladder cancer cells. PLoS One 2013;8:e73920.
21. Xue M, Li X, Li Z, Chen W. Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1alpha-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion. Tumor Biol 2014;35:6901-12.
22. Li Z, Li X, Wu S, Xue M, ChenW. Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/micro-RNA143 pathway. Cancer Sci 2014;105:951-5.
23. Karreth FA, Pandolfi PP. ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov 2013;3:1113-21.
24. Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature 2014;505:344-52.
25. Cetinbas N, Daugaard M, Mullen AR, et al. Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction. Oncogene 2015; 34:4005-10.
26. Ebert MS, Sharp PA. Emerging roles for natural microRNA sponges. Current Biol 2010;20:858-61.
27. Sen R, Ghosal S, Das S, Balti S, Chakrabarti J. Competing endogenous RNA: the key to posttranscriptional regulation. Sci World J 2014;896206.
28. Aqeilan RI, Calin GA, Croce CM. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 2010;17: 215-20.
29. Vinall RL, Kent MS, deVere White RW. Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma. Am J Vet Res 2012;73:1626-33.